AcrySof toric IOL offers spectacle independence

Article

The AcrySof toric intraocular lens (IOL) (Alcon) offers greater spectacle independence than the monofocal AcrySof SA60AT single-piece IOL (Alcon).

The AcrySof toric intraocular lens (IOL) (Alcon) offers greater spectacle independence than the monofocal AcrySof SA60AT single-piece IOL (Alcon), according to Paul Ernest from Jackson, USA.

Dr Ernest enrolled 480 patients and randomized them to receive either the control lens, AcrySof SA60AT single piece IOL (n=237), or the AcrySof toric IOL (n=243). Each patient had at least 0.75 D of regular astigmatism and age-related cataracts in one or both eyes.

The toric IOL patients reported a significantly greater rate of spectacle independence than controls (p<0.0001). Compared with controls, the percentage of toric patients achieving an uncorrected distance visual acuity (UDCVA) of 20/20 or better (19.4% versus 40.7%, respectively) or 20/25 or better (41.4% versus 63.7%, respectively) was significant (p<0.0001).

The comparison of the lenses demonstrates that the AcrySof toric IOL offers a much greater level of spectacle independence than its monofocal counterpart.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.